Jump to content

David Ho

From Wikipedia, the free encyclopedia

This is an old revision of this page, as edited by Wc2713 (talk | contribs) at 02:49, 9 March 2020. The present address (URL) is a permanent link to this revision, which may differ significantly from the current revision.

This article is about the Taiwanese scientist and HIV/AIDS researcher. For other uses, see David Ho (disambiguation).
David Ho
何大一
File:Ho.2019.jpg
Born (1952-11-03) November 3, 1952 (age 71)
Taichung, Taiwan, Republic of China
NationalityUnited States
Other namesDavid Da-i Ho, 何大一
EducationCalifornia Institute of Technology (BS)
Harvard-MIT Division of Health Sciences and Technology (MD)
Years active1990-present
Employer(s)Aaron Diamond AIDS Research Center, Columbia University
Known forAIDS research
PartnerTera Man Wong
Children4
Parent(s)Paul Ho and Sonia Jiang
David Ho
Chinese何大一
Transcriptions
Standard Mandarin
Hanyu PinyinHé Dà-yī
Gwoyeu RomatzyhHer Dahi
Wade–GilesHe2 Ta4-i1
Tongyong PinyinHé Dà-yī
Southern Min
Hokkien POJHô Tāi-it

David Da-i Ho (Chinese: 何大一; born November 3, 1952) is a Taiwanese-American doctor and HIV/AIDS researcher who has made many scientific contributions to the understanding and treatment of HIV infection.[1][2][3][4][5]

He is the founding scientific director of the Aaron Diamond AIDS Research Center and the Clyde and Helen Wu Professor of Medicine at Columbia University.

David Ho was born in Taichung, Taiwan, to Paul (何步基 Hé Bùjī, an engineer) and Sonia Ho (Jiang) (江雙如 Jiāng Shuāngrú). David Ho attended Taichung Municipal Guang-Fu Elementary School until sixth grade before immigrating to the United States with his mother and younger brother to unite with his father, who had already been in the US since 1957. He grew up in Los Angeles and graduated from John Marshall High School. He received his Bachelor of Science in biology with highest honors from the California Institute of Technology (1974)[6] and MD from the Harvard-MIT Division of Health Sciences and Technology (1978). Subsequently, he did his clinical training in internal medicine and infectious diseases at UCLA School of Medicine (1978–1982) and Massachusetts General Hospital (1982–1985), respectively. He was a resident in internal medicine at Cedars-Sinai Medical Center in Los Angeles in 1981 when he came into contact with some of the first reported cases of what was later identified as AIDS.

Career

Dr. Ho has been engaged in HIV/AIDS research since the beginning of the epidemic, initially focusing on clinical virology and select topics in HIV pathogenesis. In the mid 1990's, his research team conducted a series of elegant human studies to elucidate the dynamics of HIV replication in vivo. This knowledge, in turn, formed the foundation for their pioneering effort to treat HIV "early and hard" and in demonstrating for the first time the durable control of HIV replication in patients receiving combination antiretroviral therapy. This was the turning point in the epidemic that an automatic death sentence was transformed into a manageable disease. For the past decade and a half, Dr. Ho has shifted his research focus to developing strategies to prevent HIV transmission. A protective vaccine against HIV remains elusive despite concerted research efforts. However, Dr. Ho has been leading non-vaccine approaches to block HIV transmission that have shown considerable promise. His group was the first to demonstrate protective efficacy of a long-acting antiretroviral drug as pre-exposure prophylaxis in rhesus macaques. In fact, one such agent, cabotegravir, has been advanced into Phase-3 efficacy trials in high-risk populations, in collaboration with GlaxoSmithKline. In parallel, Dr. Ho's group has also engineered exquisitely potent antibodies that neutralize divergent strains of HIV. The most promising neutralizing agent is a bispecific monoclonal antibody that will enter a first-in-human clinical trial in 2018 with the support of the Bill & Melinda Gates Foundation. Finally, the Ho Lab is now funded by two NIH grants to pursue the use of engineered antibodies to purge the viral latent reservoir as a part of the international HIV cure effort.

Ho has published over 500 research papers as of February 2020.[7] He championed the combination anti-retroviral therapy[8] which had earlier been developed by scientists at NIAID and Merck.[9] This approach allowed the control of HIV replication in patients.[10]

Ho is a member of the Committee of 100, a Chinese American leadership organization, in addition to several scientific groups.[11]

Honors and titles

Ho has received numerous honors and awards for his scientific accomplishments. He is the recipient of 14 honorary doctorates, including those from Columbia University and Tsinghua University. On January 8, 2001, he was presented with the Presidential Citizens Medal by President Clinton.[12]

Ho was the chosen commencement speaker at Caltech, MIT, and Harvard T. H. Chan School of Public Health.[when?] Dr. Ho has been elected as a member of the American Academy of Arts and Sciences and a Academician of Academia Sinica(Taiwan). He is also a member of Chinese Academy of Engineering and the U.S. National Academy of Medicine. He was inducted into the California Hall of Fame in 2012. Ho was recognized by the Kingdom of Thailand with the Prince Mahidol Award in Medicine, and given the Distinguished Alumni Award by Caltech. Other accolades include the Ernst Jung Prize in Medicine, Mayor's Award for Excellence in Science & Technology, the Squibb Award, and the Hoechst Marion Roussel Award.[citation needed]

Ho is an honorary professor at Peking Union Medical College, Chinese Academy of Medical Sciences, Chinese Academy of Sciences, University of Hong Kong, Wuhan University, and Fudan University in China. He was a member of the Board of Overseers of Harvard University and the Board of Trustees of the California Institute of Technology. He is a former board member of the Massachusetts Institute of Technology Corporation.[13]

Ho was Time magazine's 1996 Man of the Year. Time later recalled the selection surprised both Ho and readers[14] The magazine acknowledged in 1996 that "Ho is not, to be sure, a household name. But some people make headlines while others make history."[14] Ho was even briefly mentioned when Alexander Fleming was considered for Person of the Century in 1999, since Fleming could be portrayed as representative of other disease-fighting scientists including Ho,[15] but the title ultimately went to Albert Einstein.

Ho has been elected as a member of the American Academy of Arts and Sciences, Academia Sinica (Taiwan), and the Institute of Medicine of the National Academy.[11] Dr. Ho was a member of the Board of Overseers of Harvard University and a board member of the MIT Corporation. He is currently a member of the board of trustees of the California Institute of Technology.

On December 6, 2006, California governor Arnold Schwarzenegger and First Lady Maria Shriver inducted Ho into the California Hall of Fame located at The California Museum for History, Women, and the Arts.[16] Dr. Ho was awarded Distinguished Alumni Award at California Institute of Technology in 2015. Dr. Ho received the Portrait of a Nation Prize at the National Portrait Gallery, Smithsonian Institution in 2017.

Personal life

Ho has three children: Kathryn, Jonathan, and Jaclyn. He lives with his partner, Tera Wong, and their child Jerren Ho. His family's ancestral home is Xinyu, Jiangxi Province.[17]

Sources

See also

References

  1. ^ Sen. Russ Feingold (D-WI) noted, "Without the contributions of Taiwanese Americans, we would lack the important AIDS research of Dr. David Ho. Archived 2008-09-08 at the Wayback Machine, Formosan Association for Public Affairs, MAY 2000
  2. ^ The Taiwanese Americans, page 130-131
  3. ^ Taiwanese-American HIV/AIDS academic joins team, The Taipei Times, Sep 04, 2011
  4. ^ U.S. PUBLIC TV STATIONS TO BROADCAST TAIWAN TRAVEL FEATURES Archived 2016-03-03 at the Wayback Machine, Government Information Office, Republic of China (Taiwan), 12/27/2006
  5. ^ Park, Alice (2010-01-25). "Scientist David Ho: The Man Who Could Beat AIDS". Time. Retrieved 24 January 2010.
  6. ^ "Caltech Commencement Program" (PDF). Caltech Campus Publications. 1974-06-14. Retrieved 2013-03-29.
  7. ^ (Nature 1995; Science 1996)
  8. ^ (N. Engl. J. Med. 1995; Science 1996)
  9. ^ Gulick, Roy M.; Mellors, John W.; Havlir, Diane; Eron, Joseph J.; Gonzalez, Charles; McMahon, Deborah; Richman, Douglas D.; Valentine, Fred T.; Jonas, Leslie; Meibohm, Anne; Emini, Emilio A.; Chodakewitz, Jeffrey A.; Deutsch, Paul; Holder, Daniel; Schleif, William A.; Condra, Jon H. (1997). "Treatment with Indinavir, Zidovudine, and Lamivudine in Adults with Human Immunodeficiency Virus Infection and Prior Antiretroviral Therapy". New England Journal of Medicine. 337 (11): 734–739. doi:10.1056/NEJM199709113371102. PMID 9287228.
  10. ^ (Nature 1997)
  11. ^ a b "MEMBERS | Committee 100". www.committee100.org. Retrieved 2020-02-25.
  12. ^ Mo, Steven (June 13, 2011). "AIDS Research Pioneer, David Ho, Talks To Asian Scientist Magazine". Asian Scientist.
  13. ^ "Home - The MIT Corporation". web.mit.edu. Retrieved 14 November 2017.
  14. ^ a b Time, Person of the Year: 75th Anniversary Celebration, Special Collector's Edition, Time Books, 2002, p. 108.
  15. ^ Time Millennium, Collector's Edition, Time Inc. Specials, p. 21.
  16. ^ "California Hall of Fame - California Museum". www.californiamuseum.org. Retrieved 14 November 2017.
  17. ^ "David Ho Credits His Achievements to Late Father｜Culture｜News｜WantChinaTimes.com". www.adarc.org. Retrieved 2020-02-25.
Wikimedia Commons has media related to David Ho.

Template:Members of the Chinese Academy of Engineering (2003)

Retrieved from "https://en.wikipedia.org/w/index.php?title=David_Ho&oldid=944649386"